Alecomm · Parliamentary Accountability

Public View · Owner Sign-In

Community Affairs References Committee; Reference

Public Concern: Parliamentary proposal recorded under Committees: Community Affairs References Committee; Reference.

Requested Action: That the following matter be referred to the Community Affairs References Committee for inquiry and report by 12 February 2025: The failure of Australia to adopt evidence-based safeguards on the use of puberty blockers for gender dysphoric adolescents, aligning with international best practices, with particular reference to: (a) the dangers posed by puberty blockers, as evidenced by poor-quality and inconclusive research on their safety and efficacy; (b) the inadequacy of current Australian safeguards compared to more precautionary approaches adopted in New Zealand , the United Kingdom and other nations; (c) the over-reliance on experimental treatments instead of prioritising holistic, psychological and social interventions for young people experiencing gender dysphoria; (d) the lack of regulation and oversight of off-label prescriptions of puberty blockers in Australia; (e) the absence of long-term data on the physical, mental health and fertility impacts of these treatments; (f) the Government's role in ensuring proper medical, ethical and legal standards are applied to protect vulnerable adolescents; (g) the stifling of dissenting medical and scientific views in public and policy debates on gender-affirming treatments; and (h) any other related matters.

Effect On The Original Proposal: Recorded outcomes and any procedural decisions are shown separately for each question.

Original Question Vote: 2024-11-25 · Substantive Proposal · Moved; Final Decision Not Located In The Reviewed Text

Debate Opportunity: The originating contribution and related proceedings are linked in Sources.

Original Proposal
That the following matter be referred to the Community Affairs References Committee for inquiry and report by 12 February 2025: The failure of Australia to adopt evidence-based safeguards on the use of puberty blockers for gender dysphoric adolescents, aligning with international best practices, with particular reference to: (a) the dangers posed by puberty blockers, as evidenced by poor-quality and inconclusive research on their safety and efficacy; (b) the inadequacy of current Australian safeguards compared to more precautionary approaches adopted in New Zealand , the United Kingdom and other nations; (c) the over-reliance on experimental treatments instead of prioritising holistic, psychological and social interventions for young people experiencing gender dysphoria; (d) the lack of regulation and oversight of off-label prescriptions of puberty blockers in Australia; (e) the absence of long-term data on the physical, mental health and fertility impacts of these treatments; (f) the Government's role in ensuring proper medical, ethical and legal standards are applied to protect vulnerable adolescents; (g) the stifling of dissenting medical and scientific views in public and policy debates on gender-affirming treatments; and (h) any other related matters.

Sponsors / Representatives: Pauline Hanson

Outcome: Moved; Final Decision Not Located In The Reviewed Text

Type: Committee Referral

Chamber: Senate

Jurisdiction: Australian Parliament, Australia

Recorded Date: 25/11/2024

Topics: Pauline Hanson; Committee Referral; Committees

Votes And Procedural Actions

Substantive Proposal · Refer To Committee

Date: 2024-11-25

Moved By: Pauline Hanson

Exact Question Put: That the following matter be referred to the Community Affairs References Committee for inquiry and report by 12 February 2025: The failure of Australia to adopt evidence-based safeguards on the use of puberty blockers for gender dysphoric adolescents, aligning with international best practices, with particular reference to: (a) the dangers posed by puberty blockers, as evidenced by poor-quality and inconclusive research on their safety and efficacy; (b) the inadequacy of current Australian safeguards compared to more precautionary approaches adopted in New Zealand , the United Kingdom and other nations; (c) the over-reliance on experimental treatments instead of prioritising holistic, psychological and social interventions for young people experiencing gender dysphoria; (d) the lack of regulation and oversight of off-label prescriptions of puberty blockers in Australia; (e) the absence of long-term data on the physical, mental health and fertility impacts of these treatments; (f) the Government's role in ensuring proper medical, ethical and legal standards are applied to protect vulnerable adolescents; (g) the stifling of dissenting medical and scientific views in public and policy debates on gender-affirming treatments; and (h) any other related matters.

Result: Moved; Final Decision Not Located In The Reviewed Text

Effect: Originating motion/stage as recorded in Hansard.

No named roll call recorded for this decision.

Coverage Notes: A final decision was not located for the identified stage; no failure or success is inferred for that question. Individual votes are included only for matched named roll calls. Unlisted people have no inferred vote. Parties and state labels are those in the division source.

Reference: VR93-X5R5-XJUY-4JP6